<!doctype html><html lang=en-us><head><meta name=generator content="Hugo 0.147.3"><meta charset=utf-8><meta http-equiv=X-UA-Compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><title>Scientific Advisory Board (SAB) </title><meta name=description content="ASAP has recruited a seasoned Scientific Advisory Board with extensive experience in drug discovery and development, antivirals, computational chemistry, and global access"><meta name=robots content="noindex"><meta name=author content="newpixcom"><meta property="og:url" content="https://asapdiscovery.org/sab/"><meta property="og:site_name" content="ASAP Discovery Consortium"><meta property="og:title" content="Scientific Advisory Board (SAB)"><meta property="og:description" content="ASAP has recruited a seasoned Scientific Advisory Board with extensive experience in drug discovery and development, antivirals, computational chemistry, and global access"><meta property="og:locale" content="en_us"><meta property="og:type" content="website"><div id=cookie-notice><span>We would like to use third party cookies and scripts to improve the
functionality of this website.</span>
<a id=cookie-notice-accept class="btn btn-primary btn-sm">Approve</a>
<a id=cookie-notice-deny class="btn btn-primary btn-sm">Deny</a>
<a href=/privacy class="btn btn-primary btn-sm">More info</a></div><script>function createCookie(e,t,n){var s,o="";n&&(s=new Date,s.setTime(s.getTime()+n*24*60*60*1e3),o="; expires="+s.toUTCString()),document.cookie=e+"="+t+o+"; path=/"}function readCookie(e){for(var t,s=e+"=",o=document.cookie.split(";"),n=0;n<o.length;n++){for(t=o[n];t.charAt(0)==" ";)t=t.substring(1,t.length);if(t.indexOf(s)==0)return t.substring(s.length,t.length)}return null}function eraseCookie(e){createCookie(e,"",-1)}if(readCookie("cookie-notice-option")=="true"){function loadScriptAsync(e,t){if(typeof t!="function")throw new Error("Not a valid callback for async script load");var n=document.createElement("script");n.onload=t,n.src=e,document.head.appendChild(n)}loadScriptAsync("https://www.googletagmanager.com/gtag/js?id=G-M3L857X90H",function(){window.dataLayer=window.dataLayer||[];function e(){dataLayer.push(arguments)}e("js",new Date),e("config","G-M3L857X90H",{anonymize_ip:!0})})}else readCookie("cookie-notice-option")!="false"&&(document.getElementById("cookie-notice").style.display="block");document.getElementById("cookie-notice-accept").addEventListener("click",function(){createCookie("cookie-notice-option","true",31),document.getElementById("cookie-notice").style.display="none",location.reload()}),document.getElementById("cookie-notice-deny").addEventListener("click",function(){createCookie("cookie-notice-option","false",31),document.getElementById("cookie-notice").style.display="none",location.reload()})</script><link rel=canonical href=https://asapdiscovery.org/sab/><link rel="shortcut icon" type=image/png href="data:image/png;base64,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"><link href=/css/font.css rel=stylesheet type=text/css><link href=/css/kube.css rel=stylesheet type=text/css><link href=/css/kube.legenda.css rel=stylesheet type=text/css><link href=/css/highlight.css rel=stylesheet type=text/css><link href=/css/master.css rel=stylesheet type=text/css><link href=/css/kube.demo.css rel=stylesheet type=text/css><link href=/css/custom.css rel=stylesheet type=text/css><script src=/js/jquery-2.1.4.min.js type=text/javascript></script><script type=text/javascript src=/js/tocbot.min.js></script><script src=https://kit.fontawesome.com/5812ece076.js crossorigin=anonymous></script></head><body class=page-kube><header><div class=show-sm><div id=nav-toggle-box><div id=nav-toggle-brand><a href=/>ASAP Discovery Consortium</a></div><a data-component=toggleme data-target=#top href=# id=nav-toggle><i class=kube-menu></i></a></div></div><div class=hide-sm id=top><div id=top-brand><a href=/ title=home>ASAP Discovery Consortium</a></div><nav id=top-nav-main><ul><li><a href=/pipeline/>Pipeline</a></li><li><a href=/outputs/>Outputs</a></li><li><a href=https://www.choderalab.org/news/2021/10/26/asap-avidd-proposal>Concept</a></li><li><a href=/members/>Members</a></li><li><a href=/sab/>SAB</a></li><li><a href=/faq/>FAQ</a></li><li><a href=/awards/>Awards</a></li><li><a href=/forum/>Open Science Forum</a></li><li><a href=https://postera.ai/moonshot/>COVID Moonshot</a></li><li><a href=/open-science/>Open Science</a></li></ul></nav><nav id=top-nav-extra><ul></ul></nav></div></header><main><div id=hero class=wrap><h1>Scientific Advisory Board (SAB)</h1><p>ASAP has recruited a seasoned Scientific Advisory Board with extensive experience in drug discovery and development, antivirals, computational chemistry, and global access<br></p></div><div id=main><h2>External Scientific Advisory Board (SAB) Members</h2><ul><div class="row gutters"><div class="col col-2"><img src=../members/img/people/jeremy-burrows.jpg></div><div class="col col-9"><h4><b>Jeremy Burrows</b></h4><p><b>External Scientific Advisory Board Member</b><br>Vice President, Head of Drug Discovery, Medicines for Malaria Ventures<br>web: <a href=https://www.mmv.org/about-us/our-team/jeremy-burrows>https://www.mmv.org/about-us/our-team/jeremy-burrows</a><br><i><p>Dr. Jeremy Burrows is VP, Head of Drug Discovery at Medicines for Malaria Venture (MMV). He heads up the Discovery team at MMV and works with Pharmaceutical companies, Universities and other institutions to delivery new candidate drugs for antimalarial therapy, anti-relapse, prophylaxis and transmission blocking.</p><p>Jeremy obtained a MA in chemistry and a D.Phil. in synthetic organic chemistry at Oxford University (1989-1996). In 1997 he joined ZENECA/ AstraZeneca as a medicinal chemist working in Infection, Cardiovascular and Inflammation research at Alderley Park in the UK. In 2005 he was seconded to Södertälje, Sweden in CNS/Pain where he led a section focused on Alzheimer’s disease. In 2008, he joined MMV and in 2010 became Head of the Discovery team, overseeing a growing portfolio of enabling technology, screening, Hit-to-lead and Lead Optimisation projects.</p><p>He has been involved with the delivery of numerous candidate drugs for multiple disease areas, over 30 of which have been for malaria, and has published over 150 papers, book chapters and patent applications.</p><p>He sits on the advisory and review committees for several external drug discovery collaborations within the neglected disease area including the Wellcome funded DNDi-GSK Chagas collaboration. He is a Fellow of the Royal Society of Chemistry and an Honorary Research Fellow at the Liverpool School of Tropical Medicine. He is a co-organiser of the Wellcome Practical Aspects of Drug Discovery Course.</p></i></p></div></div><hr><div class="row gutters"><div class="col col-2"><img src=../members/img/people/marti-head.jpg></div><div class="col col-9"><h4><b>Marti Head</b>
<a href=http://twitter.com/marti_sue><img width=20 src=../members/img/icons/twitter.png></a></h4><p><b>External Scientific Advisory Board Member</b><br>Executive Director of Computational and Data Sciences, Amgen<br>web: <a href=https://www.linkedin.com/in/mshead/>https://www.linkedin.com/in/mshead/</a><br><i><p>Martha S. Head (Marti) is Executive Director of Computational and Data Sciences at AMGEN, where she leads a team applying mechanistic and machine-learning computational methods to the understanding of disease biology and the discovery and design of biologic and synthetic therapeutics. Previously, she was the Director of the Joint Institute for Biological Sciences, a collaborative research effort between Oak Ridge National Laboratory (ORNL) and the University of Tennessee system and Director of Computational Biomedical Initiatives at ORNL. As director, she focused on applying the world-leading capabilities of ORNL and UT to biomedical research and health outcomes of relevance to Tennessee and the Appalachian region.</p><p>Before joining ORNL, Dr. Head spent 20 years in R&amp;D at GlaxoSmithKline Pharmaceuticals (GSK). For many of those years, Dr. Head led GSK’s U.S. Computational Chemistry team, whose accountability was to proactively and creatively apply all relevant computational tools to progressing drug discovery efforts from target selection through to selection of a candidate for clinical trials. In the final years of her time at GSK, Dr. Head led GSK’s collaboration with Palantir, a Silicon Valley data integration and exploration company, and built GSK’s Insights from Data team. While at GSK, Dr. Head was a co-creator of the Accelerating Therapeutics for Opportunities in Medicine (ATOM), a public-private partnership under the auspices of the Cancer Moonshot, and at ORNL continued to be a contributor to ATOM and a member of the ATOM Joint Research Council, and Dr. Head leads the “Molecular design and analysis to inform therapeutics related to COVID-19” project sponsored by the US Department of Energy National Virtual Biotechnology Laboratory. Dr. Head received her PhD in physical chemistry from Duke University in 1995.</p></i></p></div></div><hr><div class="row gutters"><div class="col col-2"><img src=../members/img/people/ann-kwong.jpg></div><div class="col col-9"><h4><b>Ann Kwong</b></h4><p><b>External Scientific Advisory Board Member</b><br>Principal, Kwong Pharma Consulting, LLC<br>web: <a href=https://www.linkedin.com/in/ann-d-kwong-phd-0060154/>https://www.linkedin.com/in/ann-d-kwong-phd-0060154/</a><br><i>Ann Kwong, Ph.D. has over 30 years of experience in in the biopharmaceutical industry and has helped move multiple
antiviral compounds into the clinic. At Vertex Pharmaceuticals, Dr. Kwong played a leading role in the
research, development, and commercialization of telaprevir- an HCV protease inhibitor that received
the Prix Galien Award for Best Pharmaceutical Agent in 2012. Dr. Kwong also designed Vertex’s influenza virus
program, which led to the development of pimodivir, a first in class PB2 inhibitor; she was awarded
the Gertrude Elion Memorial Award in 2020 by the International Society for Antiviral Research.
Ann founded Trek Therapeutics to develop affordable HCV treatments; and was the EVP of R&amp;D at
Dewpoint Therapeutics. She is currently Principal at Kwong Pharma Consulting, LLC. Dr. Kwong is a
co-author or inventor on numerous publications and patents and received her BA in Biology and PhD
in virology from the University of Chicago.</i></p></div></div><hr><div class="row gutters"><div class="col col-2"><img src=../members/img/people/lisa-purcell.jpg></div><div class="col col-9"><h4><b>Lisa Purcell</b></h4><p><b>External Scientific Advisory Board Member</b><br>Entrepreneur-In-Residence, Third Rock Ventures<br>web: <a href=https://www.thirdrockventures.com/people/lisa-purcell>https://www.thirdrockventures.com/people/lisa-purcell</a><br><i>Lisa Purcell, Ph.D. has been an Entrepreneur-In-Residence at Third Rock Ventures since May of 2024. Dr. Purcell’s career has been dedicated to the development of therapies within the immunology and infectious disease areas, including those for SARS-CoV-2/COVID-19. Previous to Third Rock, she served as the Senior Vice President of Research and Translational Medicine at Vir Biotechnology from 2020 to 2024. Dr. Purcell worked in both the clinical and nonclinical areas at Regeneron Pharmaceuticals for nearly 13 years focusing on the development of drugs for infectious disease, allergy and inflammation. Dr. Purcell received her B.Sc. with Honors in Biology and M.Sc. in Ecotoxicology from the University of Prince Edward Island, her Ph.D. in Parasitology from McGill University and completed her postdoctoral training at Columbia University Vagelos College of Physicians and Surgeons.</i></p></div></div><hr><div class="row gutters"><div class="col col-2"><img src=../members/img/people/wendy-young.jpg></div><div class="col col-9"><h4><b>Wendy Young</b></h4><p><b>External Scientific Advisory Board Member</b><br>Biopharma Executive, Scientific Advisor, Board Member, MPM Capital<br>web: <a href=https://www.linkedin.com/in/wendy-young-65a1572/>https://www.linkedin.com/in/wendy-young-65a1572/</a><br><i>Distinguished medicinal chemist and pharma executive. Wendy was formerly Senior Vice President at Genentech leading drug discovery. Under her leadership, more than 25 clinical candidates, in the areas of oncology, immunology, neurology, and anti-infectives progressed into development. Wendy is the inventor of fenebrutinib which is in Phase 3 trials for multiple sclerosis. Currently, Wendy is the CEO of a biotech company in stealth mode, Director and/or Scientific Advisory Board Member of several private biotechs, an Associate Editor of the Journal of Medicinal Chemistry and an advisor at GV (Google Ventures). Dr. Young brings expertise in medicinal chemistry strategy and business development to the SAB.</i></p></div></div><hr></ul><h2>Internal Scientific Advisory Board (SAB) Members</h2><ul><div class="row gutters"><div class="col col-2"><img src=../members/img/people/john-chodera.jpg></div><div class="col col-9"><h4><b>John D. Chodera</b>
<a href=http://twitter.com/jchodera><img width=20 src=../members/img/icons/twitter.png></a>
<a href=http://github.com/jchodera><img width=20 src=../members/img/icons/github.png></a></h4><p><b>Principal Investigator; Co-Investigator: Hit-to-Lead; Co-Investigator: Lead Optimization</b><br>Associate Member, Sloan Kettering Institute<br>web: <a href=http://choderalab.org>http://choderalab.org</a><br>ORCID: <a href=https://orcid.org/0000-0003-0542-119X>0000-0003-0542-119X</a>
| <a href=http://goo.gl/qO0JW>Google Scholar</a>
<i>Contact PI; Oversight of cores; Alchemical free energy calculations on <a href=http://foldingathome.org>Folding@home</a>; computational chemistry and structure-based machine learning</i></p></div></div><hr><div class="row gutters"><div class="col col-2"><img src=../members/img/people/alpha-lee.jpg></div><div class="col col-9"><h4><b>Alpha Lee</b>
<a href=http://twitter.com/iamalphalee><img width=20 src=../members/img/icons/twitter.png></a></h4><p><b>Principal Investigator; Project Lead: Hit-to-lead</b><br>Co-Founder and Chief Scientific Officer, PostEra<br>web: <a href=http://postera.ai>http://postera.ai</a><br>ORCID: <a href=https://orcid.org/0000-0002-9616-3108>0000-0002-9616-3108</a>
| <a href="https://scholar.google.com/citations?user=ECsGcPcAAAAJ&amp;hl=en&amp;oi=ao">Google Scholar</a>
<i>Oversight of early-stage discovery; artificial intelligence and machine learning for virtual synthetic libraries and automated ligand optimization; automated hit-to-lead optimization</i></p></div></div><hr><div class="row gutters"><div class="col col-2"><img src=../members/img/people/peter-sjo.jpg></div><div class="col col-9"><h4><b>Peter Sjö</b></h4><p><b>Principal Investigator; Co-Investigator: Preclinical Development</b><br>Head of Drug Discovery Programme, Drugs for Neglected Diseases initiative (DNDi)<br>web: <a href=https://dndi.org/our-people/peter-sjo/>https://dndi.org/our-people/peter-sjo/</a><br>ORCID: <a href=https://orcid.org/0000-0002-6768-0536>0000-0002-6768-0536</a>
| <a href="https://scholar.google.com/citations?user=jDx7omgAAAAJ&amp;hl=en&amp;oi=ao">Google Scholar</a>
<i>Oversight of late-stage discovery and preclinical development; preclinical development; medicinal chemistry</i></p></div></div><hr></ul><ul><div class="row gutters"><div class="col col-2"><img src=../members/img/people/ben-perry.jpg></div><div class="col col-9"><h4><b>Ben Perry</b>
<a href=http://twitter.com/MrBenGP><img width=20 src=../members/img/icons/twitter.png></a></h4><p><b>Internal Scientific Advisory Board Member</b><br>Principal, Medicxi<br>web: <a href=https://www.medicxi.com/team/ben-perry>https://www.medicxi.com/team/ben-perry</a><br>ORCID: <a href=https://orcid.org/0000-0001-6715-4213>0000-0001-6715-4213</a>
| <a href="https://scholar.google.com/citations?user=ECsGcPcAAAAJ&amp;hl=en&amp;oi=ao">Google Scholar</a>
<i><p>Ben is a Principal in the Medicxi Investment team. Prior to joining Medicxi, Ben spent over twenty years leading small molecule discovery projects in various R&amp;D organisations including the Drugs for Neglected Diseases initiative (DNDi, Geneva), Addex Therapeutics (Geneva) and UCB (Cambridge, UK) as well as co-founding the early-stage start-ups AiDD SA and MPC Therapeutics SA.</p><p>Ben received a MChem from University of Wales Swansea, a PhD in organic chemistry from Imperial College London and an EMBA from IE Business School, Madrid</p></i></p></div></div><hr></ul></div></main><footer><footer id=footer><nav><ul><li><span>ASAP Discovery</span></li><li><a href=https://www.choderalab.org/news/2021/10/26/asap-avidd-proposal>About Us</a></li><li><a href=http://twitter.com/asap_discovery>Twitter <i class="fa-brands fa-twitter"></i></a></li><li><a href=https://github.com/asapdiscovery/asapdiscovery.github.io/blob/ef39d2ca859fd53561b9e6da52db5e98e59de6e5/assets/images/icons/README.md>Image Credits</a></li><li><a href=mailto:maggie.jameson@choderalab.org>Contact Us</a></li></ul></nav></footer><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/katex.min.css integrity=sha384-wITovz90syo1dJWVh32uuETPVEtGigN07tkttEqPv+uR2SE/mbQcG7ATL28aI9H0 crossorigin=anonymous><script src=https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/katex.min.js integrity=sha384-/y1Nn9+QQAipbNQWU65krzJralCnuOasHncUFXGkdwntGeSvQicrYkiUBwsgUqc1 crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/contrib/auto-render.min.js integrity=sha384-dq1/gEHSxPZQ7DdrM82ID4YVol9BYyU7GbWlIwnwyPzotpoc57wDw/guX8EaYGPx crossorigin=anonymous></script><script>renderMathInElement(document.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}]});for(var inlineMath,tex,replaced,displayMathArray,displayMath,inlineMathArray=document.querySelectorAll("script[type='math/tex']"),i=0;i<inlineMathArray.length;i++)inlineMath=inlineMathArray[i],tex=inlineMath.innerText||inlineMath.textContent,replaced=document.createElement("span"),replaced.innerHTML=katex.renderToString(tex,{displayMode:!1}),inlineMath.parentNode.replaceChild(replaced,inlineMath);for(displayMathArray=document.querySelectorAll("script[type='math/tex; mode=display']"),i=0;i<displayMathArray.length;i++)displayMath=displayMathArray[i],tex=displayMath.innerHTML,replaced=document.createElement("span"),replaced.innerHTML=katex.renderToString(tex.replace(/%.*/g,""),{displayMode:!0}),displayMath.parentNode.replaceChild(replaced,displayMath)</script><script>renderMathInElement(document.body)</script></footer><script src=/js/kube.js type=text/javascript></script><script src=/js/kube.legenda.js type=text/javascript></script><script src=/js/master.js type=text/javascript></script></body></html>